Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Exercise and Cardiac Output01:17

Exercise and Cardiac Output

1.3K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
1.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

798
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
798
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

1.2K
Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
1.2K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

716
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
716

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Mitochondrial peptide MOTS-c suppresses systemic and cardiac inflammasome activation in a diabetic rat model.

Experimental physiology·2026
Same author

Substrate-specific mitochondrial dysfunction and metabolomic profiles in type 2 diabetic rat hearts.

Experimental physiology·2026
Same author

Mitochondrial respiration and hydrogen peroxide production rate in right atrial tissues from obese diabetic patients.

Experimental physiology·2026
Same author

Type 2 diabetes disrupts T-tubule and RyR2 organization in male but not in female rat ventricular muscle.

American journal of physiology. Heart and circulatory physiology·2026
Same author

The Absence of Collagen VI Reduces Systolic Function but Paradoxically Increases Ca<sup>2+</sup> Release in the Rat Heart.

Acta physiologica (Oxford, England)·2025
Same author

Distinct profiles of mitochondrial bioenergetics and redox balance in left atrial and ventricular myocardium in the healthy rat heart.

Experimental physiology·2025

関連する実験動画

Updated: Sep 8, 2025

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

7.6K

ダニカムチブは心臓のメカニカル効率を高める

Trent Meehan1, Toan Pham1, Kenneth Tran1

  • 1Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.

The Journal of physiology
|September 5, 2025
PubMed
まとめ
この要約は機械生成です。

ダニカムチブは心臓のミオシン活性化剤で,カルシウム循環のためのエネルギー消費を増加させずに,発力力と作業を増加させることで心臓の筋肉の効率を高めます. この研究は心臓のメカニズムと エネルギー学における 二重の利点を明らかにしています

キーワード:
心臓のエネルギークロスブリッジ効率暑さについてミオシン活性化剤ワーク・ループの収縮

さらに関連する動画

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.4K
Mechanical Control of Relaxation Using Intact Cardiac Trabeculae
07:51

Mechanical Control of Relaxation Using Intact Cardiac Trabeculae

Published on: February 17, 2023

1.3K

関連する実験動画

Last Updated: Sep 8, 2025

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

7.6K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.4K
Mechanical Control of Relaxation Using Intact Cardiac Trabeculae
07:51

Mechanical Control of Relaxation Using Intact Cardiac Trabeculae

Published on: February 17, 2023

1.3K

科学分野:

  • 心血管の生理学
  • 筋肉の収縮の生理学
  • 心臓のエネルギー

背景:

  • ダニカムチブは心臓特異のミオシン活性化剤です.
  • 心臓の機能を改善するための臨床前試験と臨床試験が進行中です.

研究 の 目的:

  • ダニカムチブが心臓のエネルギーに 与える影響を評価するために
  • ダニカムチブが心筋の力や効率に与える影響の仕組みを明らかにする.

主な方法:

  • ネズミの隔離された心室のトラベキュラが in vitro 試験に使用された.
  • 筋肉の熱出力はイソメトリックとワーク・ループの収縮時に測定された.
  • トラベキュラは,力,熱生成,効率に対する効果を定量化するためにdanicamtiv (5 μM) に暴露された.

主要な成果:

  • ダニカムティブは 筋肉の熱と 交差点の熱を増加させた.
  • イソメトリックな動きを遅らせて 運動を短縮した
  • 機械効率は,熱生産よりも労働出力の増加により改善され,Ca2+サイクルエネルギーには影響はなかった.

結論:

  • ダニカムティブは,力発生とエネルギー消費の関係を最適化することで,心臓の機械的効率を改善します.
  • そのメカニズムは,カルシウム処理のエネルギーコストを増やすことなく,アクトミオシン相互作用を強化することを含む.
  • ダニカムチブは心臓に 機械的・エネルギー的な効果を もたらす イノトロピック剤として有望である.